Characterızatıon Of Musk Wıllow Extract For Antıcarcınogenıc Phytochemıcal Compounds

2012-12-31
During past decades, several naturally occurring compounds have been studied in terms of their potential chemopreventive role in colorectal cancer development and various in vitro and in vivo models supported their antiproliferative and cancer preventive abilities. One such candidate is an extract from willow species. Musk Willow, a Salix species endogenous to the Middle East, has not been examined to date for its anticarcinogenic effects. We have previously shown that the extracts from these plants have high amounts of salicin, potent antioxidant activity and significant amounts of phenolic compounds famed for their immunomodulatory and anti-inflammatory activities (Enayat and Banerjee 2009). Sustaining proliferative signaling, evading growth suppressors, utilizing mechanisms to escape from programmed cell death (apoptosis), enhanced motility and ability of invasion as well as anchorage independent growth are some of the major hallmarks of carcinogenesis. Therefore, in order to study the anticarcinogenic effect of extracts from Musk Willow we treated HCT-116 and HT-29 colon cancer cell lines as well as a non-transformed colon fibroblast CCD-18Co cell line with the ethanolic extract of bark. Our preliminary data indicate that the extract exerted strong antiproliferative, proapoptotic and antimetastatic effects on both colon cancer cell lines without being toxic for nontransformed colon fibroblast cells. Therefore, we are proposing to further investigate the anticarcinogenic role of extract from Musk Willow and analyze the crude extract for its active constituents which could be responsible for the observed antitumorogenic effects in HCT-116 and HT-29 colon cancer cell lines. Towards this objective, we propose to: • Confirm the effect of the extract on apoptosis by Annexin V apoptotic assay using Flow cytometry • Determine the effects of the extract on the cell cycle by the cell cycle analysis using Flow cytometry. • Determine the antimetastatic potential of the extract by examining its effect on motility and invasion of cancer cells using an in vitro wound healing assay and Invasion through Matrigel respectively. • Determine the effects of the extract on anchorage independent growth of the extract by soft agar colony formation assay. • Partition the ethanolic extract of bark of Willow into petroleum ether, ethyl acetate, butanol and water fractions by solvent-solvent fractionation • Define the bioactivity of each fraction on HCT-116 and HT-29 colon cancer cell lines using MTT cell proliferation assay.

Suggestions

pH Responsive nano carriers for anti cancer drug delivery
Bagherifam, Shahla; Hasırcı, Nesrin; Hasırcı, Vasıf Nejat; Department of Polymer Science and Technology (2013)
In the recent years, development of various organic and inorganic nano-sized systems has gained great interests especially for cancer diagnosis and treatment and intense researches are carried out in this area. Regarding to the recent trends for drug delivery system design, the novel approaches for drug carriers are mainly based on development of smart and nano-size drug carriers which are targeted to cancer cells. Hence, for an effective tumor-targeted delivery device, besides its chemical structure furthe...
MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells
Cagatay, Seda Tuncay; Cimen, Ismail; SAVAŞ, BERNA; Banerjee, Sreeparna (Springer Science and Business Media LLC, 2013-04-01)
Although metastasis associated protein 1 (MTA1) has been widely linked to tumor metastasis, the relevant mechanisms remain to be elucidated, especially in colorectal cancer (CRC). Here, we have investigated the link between MTA1, metastasis and epithelial-mesenchymal transition (EMT) in CRC. Eighteen normal colon tissues and 91 resected tumor samples were analyzed for MTA1 expression by immunohistochemistry (IHC). IHC indicated low or no nuclear MTA1 expression in the normal tissues and significantly higher...
Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer
Gündüz, Ufuk; Tansik, Gulistan; Mutlu, Pelin; Unsoy, Gozde; YAKAR, ARZU; Khodadust, Rouhollah; Gunduz, Gungor (2014-07-01)
Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. Another major problem is the drug resistance development before or during the treatment. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings. The studies aim targeted drug delivery to tumor site. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be target...
İdarubisin yüklü manyetik nanoparçacıkların sentezlenmesi ve MCF-7 meme kanseri hücre hattına uygulanması
Gündüz, Güngör; Yakar, Arzu; Gündüz, Ufuk(2012)
Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings of chemotherapeutics. These studies aim targeted drug delivery to tumor side at the right time. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be targeted to tumor site by an externally applied magnet...
Preparation of polyethylene glycol coated magnetic nanoparticles for targeting of cancer cells
Keskin, Tuğba; Gündüz, Ufuk; Department of Biology (2012)
Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings of chemotherapeutics. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be targeted to tumor site by an externally applied magnetic field. In this study, it is aimed to synthesize folic acid conjugated; ...
Citation Formats
S. Banerjee, “Characterızatıon Of Musk Wıllow Extract For Antıcarcınogenıc Phytochemıcal Compounds,” 2012. Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/59867.